domenica 31 maggio 2020

FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Disease - Tauvid (flortaucipir F18)

Fonte: FDA Food and Drug Administration

Link all'articolo completo